MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction

Eric Rytkin,1 Karin Mirzaev,1 Irina Bure,1 Kristina Akmalova,1 Sherzod Abdullaev,1 Anastasiia Kachanova,1 Valery Smirnov,2,3 Elena Grishina,1 Natalia Lyakhova,4 Elena Aleshkovich,4 Anna Saribekian,2 Denis Andreev,2 Alexey Shabunin,4 Dmitry Sychev1 1Institute for Molecular and Personalized Medicine,...

Full description

Bibliographic Details
Main Authors:	Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-12-01
Series:	Pharmacogenomics and Personalized Medicine
Subjects:	biomarker mirna polymorphism acute coronary syndrome pharmacogenomics
Online Access:	https://www.dovepress.com/micrornas-as-novel-biomarkers-for-p2y12--inhibitors-resistance-predict-peer-reviewed-fulltext-article-PGPM

Similar Items

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
by: Eric Rytkin, et al.
Published: (2023-06-01)

Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors
by: E I Rytkin, et al.
Published: (2019-08-01)

GENETICS OF CLOPIDOGREL RESISTANCE: RECENT DATA
by: K. B. Mirzaev, et al.
Published: (2015-10-01)

Clinical and pharmacological technologies of personalized medicine: what now and what will happen?
by: D. A. Sychev
Published: (2019-12-01)

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population
by: K. B. Mirzaev, et al.
Published: (2019-07-01)

Personalized medicines – are pharmacists ready for the challenge?
by: Kennedy MJ
Published: (2018-09-01)

Identification of Cumin (<i>Cuminum cyminum</i>) MicroRNAs through Deep Sequencing and Their Impact on Plant Secondary Metabolism
by: Almendra Reyes-Calderón, et al.
Published: (2023-04-01)

Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
by: Rytkin E, et al.
Published: (2017-09-01)

Clinical and statistical consideration in personalized medicine /
by: Carini, Claudio, et al.
Published: (2014)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
by: Lusi Zhang, et al.
Published: (2022-09-01)

CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome
by: Mirzaev KB, et al.
Published: (2017-04-01)

Data case Allopurinol Allergy
by: Hardyanto Soebono, Hardyanto
Published: (2022)

Epigenetic targets in drug discovery /
by: Sippl, Wolfgang, et al.
Published: (c200)

Pharmacogenomics in drug discovery and development /
by: Yan, Qing, 1971-
Published: (2008)

Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine
by: Fani Chatzopoulou, et al.
Published: (2022-02-01)

The Relationship Between Larynx Cancer and MicroRNAs
by: Murat Kaya, et al.
Published: (2020-09-01)

The Development of a Personalised Training Framework: Implementation of Emerging Technologies for Performance
by: Craig Pickering, et al.
Published: (2019-05-01)

Approaches to manipulating microRNAs in neurogenesis
by: Haijun eZhang, et al.
Published: (2013-01-01)

Challenges in microRNAs’ targetome prediction and validation
by: Jesus Eduardo Rojo Arias, et al.
Published: (2019-01-01)

Effect of polymorphisms in CYP3A4*22 (rs35599367) C>T, CYP3A5*3 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results
by: I. N. Sychev, et al.
Published: (2021-04-01)

Functional genomics and gene chips - the use in research and clinical medicine
by: L Joos, et al.
Published: (2003-01-01)

Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: The first meta-analysis of Russian prospective studies
by: D A Sychev, et al.
Published: (2014-04-01)

Dysregulation of MicroRNAs in cancer
by: Chen Pai-Sheng, et al.
Published: (2012-10-01)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
by: D. Ivashchenko, et al.
Published: (2022-06-01)

Research Progress of MicroRNAs in Spinal Cord Injury
by: Zhi-Zhong Deng, et al.
Published: (2023-02-01)

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
by: Sychev DA, et al.
Published: (2020-01-01)

Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
by: Nicole D. Armstrong, et al.
Published: (2022-07-01)

Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review
by: Lisa Brown, et al.
Published: (2021-09-01)

High-Evidence, Actionable Phenotype Gene Distribution in a Multispecialty, Tertiary Care Clinic: Potentially Actionable Genes and a Referring Department Profile
by: Blake Bartlett, et al.
Published: (2023-06-01)

INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE
by: Gurinder Johal, et al.
Published: (2016-05-01)

Are Community Pharmacists Ready to Deliver Pharmacogenomics Testing Services?
by: Heba Ghazal, et al.
Published: (2023-10-01)

Clinical Application and Educational Training for Pharmacogenomics
by: Jason W. Guy, et al.
Published: (2020-09-01)

by: Kathleen B Orrico
Published: (2019-12-01)

Regulatory MicroRNA Networks: Complex Patterns of Target Pathways for Disease-related and Housekeeping MicroRNAs
by: Sachli Zafari, et al.
Published: (2015-06-01)

Mechanisms of action of cytoplasmic microRNAs. Part 1. Mechanisms of interaction of microRNA and mRNA molecules. Influence of microRNAs on translation
by: A.E. Abaturov, et al.
Published: (2022-04-01)

Pharmacogenomics of analgesics in anesthesia practice: A current update of literature
by: Keith Gray, et al.
Published: (2018-01-01)

Structure of the distribution of genetic determinants of the efficacy and safety of non-steroidal anti-inflammatory drugs in the Russian population: focus on CYP2C8, PTGS1 and PTGS2
by: N. P. Denisenko, et al.
Published: (2022-02-01)

Circulating microRNAs: Promising candidates serving as novel biomarkers of acute hepatitis
by: Natalia eElfimova, et al.
Published: (2012-12-01)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022-11-01)

MicroRNAs as Potential Biomarkers in Pituitary Adenomas
by: Simone Donati, et al.
Published: (2021-09-01)